CHRONIC URTICARIA INDEX

Brand	Owner	Address	Description
CU INDEX	VIRACOR-IBT LABORATORIES, INC.	1001 NW Technology Drive Lee's Summit MO 64086	CHRONIC URTICARIA INDEX;Providing medical testing services, namely, providing testing services in the field of chronic urticaria;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention relates to defined peptides and the quantitative determination thereof in body fluids of patients suffering from progredient chronic dementia, in relation to the concentration of said peptides in a control group. The inventive peptides come from a protein precursor having the corresponding gene, are processed in a specific manner, and are optionally post-translationally modified, especially phosphorylized. An increase in the concentrations of these peptides or the corresponding non-processed protein indicates progredient chronic dementia. Progredient chronic dementia is detected by identifying the peptides and/or the protein individually or in combinations. The invention also relates to the use of said peptides for controlling the course of progredient chronic dementia and for the prognosis of progredient chronic dementia, especially for complementing or replacing mini-mental scores, and for developing therapeutic agents to combat progredient chronic dementia such as Alzheimer's disease.